Business
Clinitech Laboratory Limited Press Release Aug 21 2025
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Siddhesh Anant Nayak
About this update from Clinitech Laboratory Limited
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Siddhesh Anant Nayak View Attachment
View stock analysis, news, and events for Clinitech Laboratory Limited